This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Genital Herpes Treatment Market

Market Insights on Genital Herpes Treatment covering sales outlook, demand forecast & up-to-date key trends

Genital Herpes Treatment Market by Drug Type (Acyclovir, Valacyclovir, Famciclovir), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), Route of Administration, Indication & Region - Forecast to 2021-2031

Genital Herpes Treatment Market Snapshot

[279 Pages Report] Future Market Insights (FMI) in its latest market analysis forecasts that genital herpes treatment sales will accelerate at 1.5x in next ten years reaching the market valuation of US$ 2881.8 Mn by the end of 2031.

North America Genital Herpes Treatment Market will hold around 34.3% of global market share by 2021 owing to rising prevalence of genital herpes in U.S. and increasing healthcare spending in the region, as per FMI’s finding.

Growth predictions remain positive for Europe due to rising awareness regarding sexually transmissible infections and presence of leading market players in the U.K. and Germany. Spurred by this, the Europe genital herpes treatment market is projected to grow at about 3.4% CAGR during the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

Key Points Covered in Genital Herpes Treatment Market Study

  • Genital Herpes Treatment Market estimates and forecast 2021 – 2031
  • Key drivers and restrains impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competitive Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact On Genital Herpes Treatment Market and How to Navigate
  • Recommendation on Key Winning Strategies

2016 – 2020 Genital Herpes Treatment Market Outlook In Comparison to 2021 – 2031 Forecasts

Genital herpes cases are on the rise in western hemisphere especially in U.S., U.K. and Germany. The Center of Disease Control and Prevention states that one out of every six people in U.S. between the ages of 14 to 49 years is affected with genital herpes.

Increase in demand for genital herpes treatment will create prospects for expansion of the market. FMI reports that the genital herpes treatment market showcased a modest growth of 4% CAGR in past five years.

Rising cases of genital herpes in countries in Asia such as China and India will rev up growth opportunities for the market. The growth trend will continue in response to increasing healthcare spending registered in emerging economies.

Vaccine development for genital herpes is on the cards as pharmaceutical market leaders are focusing on new drug development and are also collaborating with research institutes for clinical trials and faster product development.

For instance, Sanofi Pasteur in collaboration with National Institute of Allergy and Infectious Diseases is currently developing a herpes vaccine called HSV529 (HSV15). The vaccine is classified as a replication-defective virus which means the virus possesses all the HSV virus components except two proteins important UL5 and UL29, involved in viral DNA replication.

In March 2021, GlaxoSmithKline plc began its phase 1 human clinical trials for its experimental HSV-2 vaccine to study the reactogenicity, safety, and immunogenicity of four different dose levels of the vaccine in healthy participants aged 18-40 years.

Rapid advancement in the field of virology and increasing investment towards modern medicine and therapeutic treatment development will boost the genital herpes treatment market growth globally throughout upcoming decade.

Genital Herpes Treatment Market Download Report Brochure

Famciclovir to emerge as another lucrative drug type after a long rule by Acyclovir

The genital herpes treatment includes the use of drug types like Acyclovir that can treat herpes virus infections, including shingles. This medication does not cure herpes, but may prevent herpes sores or blisters.

It is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Zovirax is the main brand available in the market for genital herpes. It can also treat chickenpox.

The other one is Valacyclovir which is used to treat infections caused by certain types of viruses. In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster).

In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. It is an influenza antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. Famciclovir is an antiviral drug. However, it is not a cure for these infections.

The viruses that cause these infections continue to live in the body even between outbreaks. Famvir is typically used as a one-time treatment that stops the spread or prevents the symptoms from becoming a hassle.

It treats shingles caused by herpes zoster. It also treats outbreaks of herpes simplex that cause cold sores around the mouth, sores around the anus, and genital herpes.

Among these drug types prevalent in the genital herpes treatment, Acyclovir segment dominated the global genital herpes treatment market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period.

However, Famciclovir is a drug type that is expected to gain popularity in the forecast period, and grow at a high CAGR of 5.0% during the forecast period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Increasing demand for genital herpes treatment drugs by homosexuals to be observed in the coming years

The detailed analysis of genital herpes treatment market has helped the researchers to get crucial insights. It includes results like more prevalence of HSV-2 in homosexuals. Chances of genital herpes are more in the male same-sex partnership compared to female same-sex partnership. Homosexual men are known to be at high risk for herpes simplex virus (HSV), which can be transmitted by direct intimate contact with a person who is shedding virus, and not only through ano-genital sex.

Herpes virus type 2 (HSV2) is generally considered as a useful marker for sexual behavior in a population 50% of the homosexual population in Latin America has the risk of sexually transmitted diseases such as HSV-2 genital herpes and HIV, which would increase the demand for genital herpes treatment and drive the market.

A new trend depicts increasing clinical trial of vaccines for genital herpes

Companies are increasing the clinical trials for genital herpes vaccine for advance prevention & treatment of genital herpes. Geneva is developing vaccines for genital herpes and doing clinical trial of GEN-003. It is potentially the first-ever therapeutic vaccine for a chronic infection and first advancement in the treatment of genital herpes in more than 20 years. GEN-003 is a Phase 3-ready investigational immunotherapy for the treatment of genital herpes infections. These new developments will increase the growth of the genital herpes treatment market especially in Western Europe.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Global Genital Herpes Treatment Market: Top Companies

Some of the leading companies mentioned in the research report are Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Sun Pharmaceuticals Industries Ltd., Mylan N.V., Pfizer Inc., GlaxoSmithKline plc, Dr. Reddy’s Laboratories, ltd., Novartis AG, Valeant Pharmaceuticals International Inc. etc.

This list is indicative - full details about prominent genital herpes treatment manufacturers is available upon request

Genital herpes Treatment Market – Report Scope

Attribute

Details

Genital Herpes Treatment Market Forecast Period

2021 – 2031

Historical Data Available for

2017 – 2027

Genital Herpes Treatment Market Analysis

US$ Mn for Value & Units for Volume

Key Regions Covered

North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan,  Japan, and Middle East and Africa

Key Countries Covered

U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, EU-5, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Denmark, Finland, Iceland, Norway, Sweden), Rest of Western Europe, Poland, Russia, Rest of Eastern Europe, China, India, Japan, GCC Countries, South Africa, Israel, Turkey, Iran, Rest of Middle East & Africa, Australia, New Zealand, South Korea, the Philippines, Malaysia, and Thailand

Genital Herpes Treatment Market - Key Segments Covered

Drug type, Distribution Channel, Route of Administration, Indication and Region

Key Companies Profiled

  • Teva Pharmaceutical Industries Ltd.
  • Abbott Laboratories
  • Sun Pharmaceuticals Industries Ltd.
  • Mylan N.V.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Dr. Reddy’s Laboratories, ltd.
  • Novartis AG
  • Valeant Pharmaceuticals International Inc. etc.

Genital Herpes Treatment Market - Report Coverage

Market Overview, Market Background, Market Forecast, Segmental Analysis, Regional Profiling and Competition Analysis

Customization & Pricing

Available upon Request

Key Segments Covered in Genital herpes treatment Market Study

Drug Type:

  • Acyclovir
  • Valacyclovir
  • Famciclovir

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

Route of Administration:

  • Oral
  • Topical
  • Injectable

Indication:

  • HSV-1
  • HSV-2

 Key Regions/Countries Covered:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Ex. Japan (APEJ)
  • Japan
  • Middle East & Africa

Frequently Asked Questions

Driven by increasing prevalence of genital herpes in younger population across the globe, the genital herpes treatment market is forecast to grow at 4.76% from 2021, reaching the valuation of US$ 1947.2 Mn in 2021.

Between 2016 and 2020, the genital herpes treatment market grew at a 4.0% CAGR.

The global genital herpes treatment sale is forecast to exceed the valuation of US$ 2881.8 Mn by the end of 2031.

Leading countries driving the production of the genital herpes treatment are U.S., China, and India.

Demand registered in North America will continue rising, backed increasing sales in the U.S. and Canada, the North America will engulf around 34.2% of global market share by 2031.

Novartis AG, Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd and Abbott Laboratories are the top five companies operating in the market.

Top five market players account for around 54.5% of the global genital herpes treatment market share.

Genital herpes treatment sales will increase at 3.4% CAGR in Europe, backed by rising demand in the U.K., Germany, and other countries.

Leading countries driving demand in the genital herpes treatment market are U.S., China, India Germany, and U.K.

Japan and China held 7.1% and 3.6% share, respectively in the overall genital herpes treatment market in 2021.

Table of Content

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Genital Herpes Treatment Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. North America Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) By Country, 2012-2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016

4.5.1. Acyclovir

4.5.2. Valacyclovir

4.5.3. Famciclovir

4.6. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027

4.6.1. Acyclovir

4.6.2. Valacyclovir

4.6.3. Famciclovir

4.7. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016

4.7.1. Oral

4.7.2. Topical

4.7.3. Injectable

4.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

4.8.1. Oral

4.8.2. Topical

4.8.3. Injectable

4.9. Historical Market Size (US$ Mn) By Indication, 2012-2016

4.9.1. HSV-1

4.9.2. HSV-2

4.10. Market Size (US$ Mn) Forecast By Indication, 2017-2027

4.10.1. HSV-1

4.10.2. HSV-2

4.11. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

4.11.1. Hospital Pharmacies

4.11.2. Retail Pharmacies

4.11.3. Online Pharmacies

4.11.4. Drug Stores

4.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

4.12.1. Hospital Pharmacies

4.12.2. Retail Pharmacies

4.12.3. Online Pharmacies

4.12.4. Drug Stores

4.13. Drivers and Restraints: Impact Analysis

4.14. Market Attractiveness Analysis

4.14.1. By Country

4.14.2. By Drug Type

4.14.3. By Route of Administration

4.14.4. By Indication

4.14.5. By Distribution Channel

4.15. Key Representative Market Participants

4.16. Key Participants Market Presence (Intensity Map)

5. Western Europe Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) By Country, 2012-2016

5.3.1. Germany

5.3.2. U.K

5.3.3. France

5.3.4. Italy

5.3.5. Spain

5.3.6. Rest of Western Europe

5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

5.4.1. Germany

5.4.2. U.K

5.4.3. France

5.4.4. Italy

5.4.5. Spain

5.4.6. Rest of Western Europe

5.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016

5.5.1. Acyclovir

5.5.2. Valacyclovir

5.5.3. Famciclovir

5.6. Historical Market Size (US$ Mn) By Drug Type 2012-2016

5.6.1. Acyclovir

5.6.2. Valacyclovir

5.6.3. Famciclovir

5.7. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027

5.7.1. Acyclovir

5.7.2. Valacyclovir

5.7.3. Famciclovir

5.8. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016

5.8.1. Oral

5.8.2. Topical

5.8.3. Injectable

5.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

5.9.1. Oral

5.9.2. Topical

5.9.3. Injectable

5.10. Historical Market Size (US$ Mn) By Indication, 2012-2016

5.10.1. HSV-1

5.10.2. HSV-2

5.11. Market Size (US$ Mn) Forecast By Indication, 2017-2027

5.11.1. HSV-1

5.11.2. HSV-2

5.12. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

5.12.1. Hospital Pharmacies

5.12.2. Retail Pharmacies

5.12.3. Online Pharmacies

5.12.4. Drug Stores

5.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

5.13.1. Hospital Pharmacies

5.13.2. Retail Pharmacies

5.13.3. Online Pharmacies

5.13.4. Drug Stores

5.14. Drivers and Restraints: Impact Analysis

5.15. Market Attractiveness Analysis

5.15.1. By Country

5.15.2. By Drug Type

5.15.3. By Route of Administration

5.15.4. By Indication

5.15.5. By Distribution Channel

5.16. Key Representative Market Participants

5.17. Key Participants Market Presence (Intensity Map)

6. Eastern Europe Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) By Country, 2012-2016

6.3.1. Russia

6.3.2. Poland

6.3.3. Rest of Eastern Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

6.4.1. Russia

6.4.2. Poland

6.4.3. Rest of Eastern Europe

6.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016

6.5.1. Acyclovir

6.5.2. Valacyclovir

6.5.3. Famciclovir

6.6. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027

6.6.1. Acyclovir

6.6.2. Valacyclovir

6.6.3. Famciclovir

6.7. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016

6.7.1. Oral

6.7.2. Topical

6.7.3. Injectable

6.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

6.8.1. Oral

6.8.2. Topical

6.8.3. Injectable

6.9. Historical Market Size (US$ Mn) By Indication, 2012-2016

6.9.1. HSV-1

6.9.2. HSV-2

6.10. Market Size (US$ Mn) Forecast By Indication, 2017-2027

6.10.1. HSV-1

6.10.2. HSV-2

6.11. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

6.11.1. Hospital Pharmacies

6.11.2. Retail Pharmacies

6.11.3. Online Pharmacies

6.11.4. Drug Stores

6.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

6.12.1. Hospital Pharmacies

6.12.2. Retail Pharmacies

6.12.3. Online Pharmacies

6.12.4. Drug Stores

6.13. Drivers and Restraints: Impact Analysis

6.14. Market Attractiveness Analysis

6.14.1. By Country

6.14.2. By Drug Type

6.14.3. By Route of Administration

6.14.4. By Indication

6.14.5. By Distribution Channel

6.15. Key Representative Market Participants

6.16. Key Participants Market Presence (Intensity Map)

7. Latin America Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Trends

7.3. Historical Market Size (US$ Mn) By Country, 2012-2016

7.3.1. Brazil

7.3.2. Mexico

7.3.3. Rest of Latin America

7.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

7.4.1. Brazil

7.4.2. Mexico

7.4.3. Rest of Latin America

7.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016

7.5.1. Acyclovir

7.5.2. Valacyclovir

7.5.3. Famciclovir

7.6. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027

7.6.1. Acyclovir

7.6.2. Valacyclovir

7.6.3. Famciclovir

7.7. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016

7.7.1. Oral

7.7.2. Topical

7.7.3. Injectable

7.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

7.8.1. Oral

7.8.2. Topical

7.8.3. Injectable

7.9. Historical Market Size (US$ Mn) By Indication, 2012-2016

7.9.1. HSV-1

7.9.2. HSV-2

7.10. Market Size (US$ Mn) Forecast By Indication, 2017-2027

7.10.1. HSV-1

7.10.2. HSV-2

7.11. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

7.11.1. Hospital Pharmacies

7.11.2. Retail Pharmacies

7.11.3. Online Pharmacies

7.11.4. Drug Stores

7.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

7.12.1. Hospital Pharmacies

7.12.2. Retail Pharmacies

7.12.3. Online Pharmacies

7.12.4. Drug Stores

7.13. Drivers and Restraints: Impact Analysis

7.14. Market Attractiveness Analysis

7.14.1. By Country

7.14.2. By Drug Type

7.14.3. By Route of Administration

7.14.4. By Indication

7.14.5. By Distribution Channel

7.15. Key Representative Market Participants

7.16. Key Participants Market Presence (Intensity Map)

8. Asia Pacific Excluding Japan Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Historical Market Size (US$ Mn) By Country, 2012-2016

8.3.1. China

8.3.2. India

8.3.3. Australia and New Zealand

8.3.4. ASEAN

8.3.5. Rest of APEJ

8.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

8.4.1. China

8.4.2. India

8.4.3. Australia and New Zealand

8.4.4. ASEAN

8.4.5. Rest of APEJ

8.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016

8.5.1. Acyclovir

8.5.2. Valacyclovir

8.5.3. Famciclovir

8.6. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027

8.6.1. Acyclovir

8.6.2. Valacyclovir

8.6.3. Famciclovir

8.7. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016

8.7.1. Oral

8.7.2. Topical

8.7.3. Injectable

8.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

8.8.1. Oral

8.8.2. Topical

8.8.3. Injectable

8.9. Historical Market Size (US$ Mn) By Indication, 2012-2016

8.9.1. HSV-1

8.9.2. HSV-2

8.10. Market Size (US$ Mn) Forecast By Indication, 2017-2027

8.10.1. HSV-1

8.10.2. HSV-2

8.11. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

8.11.1. Hospital Pharmacies

8.11.2. Retail Pharmacies

8.11.3. Online Pharmacies

8.11.4. Drug Stores

8.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

8.12.1. Hospital Pharmacies

8.12.2. Retail Pharmacies

8.12.3. Online Pharmacies

8.12.4. Drug Stores

8.13. Drivers and Restraints: Impact Analysis

8.14. Market Attractiveness Analysis

8.14.1. By Country

8.14.2. By Drug Type

8.14.3. By Route of Administration

8.14.4. By Indication

8.14.5. By Distribution Channel

8.15. Key Representative Market Participants

8.16. Key Participants Market Presence (Intensity Map)

9. Japan Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Regional Market Dynamics

9.2.1. Drivers

9.2.2. Restraints

9.2.3. Trends

9.3. Historical Market Size (US$ Mn) By Drug Type 2012-2016

9.3.1. Acyclovir

9.3.2. Valacyclovir

9.3.3. Famciclovir

9.4. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027

9.4.1. Acyclovir

9.4.2. Valacyclovir

9.4.3. Famciclovir

9.5. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016

9.5.1. Oral

9.5.2. Topical

9.5.3. Injectable

9.6. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

9.6.1. Oral

9.6.2. Topical

9.6.3. Injectable

9.7. Historical Market Size (US$ Mn) By Indication, 2012-2016

9.7.1. HSV-1

9.7.2. HSV-2

9.8. Market Size (US$ Mn) Forecast By Indication, 2017-2027

9.8.1. HSV-1

9.8.2. HSV-2

9.9. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

9.9.1. Hospital Pharmacies

9.9.2. Retail Pharmacies

9.9.3. Online Pharmacies

9.9.4. Drug Stores

9.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

9.10.1. Hospital Pharmacies

9.10.2. Retail Pharmacies

9.10.3. Online Pharmacies

9.10.4. Drug Stores

9.11. Drivers and Restraints: Impact Analysis

9.12. Market Attractiveness Analysis

9.12.1. By Country

9.12.2. By Drug Type

9.12.3. By Route of Administration

9.12.4. By Indication

9.12.5. By Distribution Channel

9.13. Key Representative Market Participants

9.14. Key Participants Market Presence (Intensity Map)

10. Middle East and Africa Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Regional Market Dynamics

10.2.1. Drivers

10.2.2. Restraints

10.2.3. Trends

10.3. Historical Market Size (US$ Mn) By Country, 2012-2016

10.3.1. GCC Countries

10.3.2. South Africa

10.3.3. North Africa

10.3.4. Rest of Middle East and Africa

10.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

10.4.1. GCC Countries

10.4.2. South Africa

10.4.3. Rest of Middle East and Africa

10.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016

10.5.1. Acyclovir

10.5.2. Valacyclovir

10.5.3. Famciclovir

10.6. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027

10.6.1. Acyclovir

10.6.2. Valacyclovir

10.6.3. Famciclovir

10.7. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016

10.7.1. Oral

10.7.2. Topical

10.7.3. Injectable

10.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

10.8.1. Oral

10.8.2. Topical

10.8.3. Injectable

10.9. Historical Market Size (US$ Mn) By Indication, 2012-2016

10.9.1. HSV-1

10.9.2. HSV-2

10.10. Market Size (US$ Mn) Forecast By Indication, 2017-2027

10.10.1. HSV-1

10.10.2. HSV-2

10.11. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

10.11.1. Hospital Pharmacies

10.11.2. Retail Pharmacies

10.11.3. Online Pharmacies

10.11.4. Drug Stores

10.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

10.12.1. Hospital Pharmacies

10.12.2. Retail Pharmacies

10.12.3. Online Pharmacies

10.12.4. Drug Stores

10.13. Drivers and Restraints: Impact Analysis

10.14. Market Attractiveness Analysis

10.14.1. By Country

10.14.2. By Drug Type

10.14.3. By Route of Administration

10.14.4. By Indication

10.14.5. By Distribution Channel

10.15. Key Representative Market Participants

10.16. Key Participants Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

13.1. Market Structure

13.2. Market Share Analysis (2016)

13.3. Competition Intensity Mapping By Market Taxonomy

13.4. Competition Dashboard

13.5. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

13.5.1. Teva Pharmaceutical Industries Ltd.

13.5.2. Abbott Laboratories

13.5.3. Sun Pharmaceuticals Industries Ltd.

13.5.4. Mylan N.V.

13.5.5. Pfizer Inc.

13.5.6. GlaxoSmithKline plc.

13.5.7. Dr. Reddy’s Laboratories, ltd.

13.5.8. Novartis AG

13.5.9. Valeant Pharmaceuticals International Inc.

14. Global Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027 By Region

14.1. Introduction / Key Findings

14.2. Historical Market Size (US$ Mn) By Region, 2012-2016

14.2.1. North America

14.2.2. Western Europe

14.2.3. Eastern Europe

14.2.4. Latin America

14.2.5. Asia Pacific Excluding Japan

14.2.6. Japan

14.2.7. Middle East and Africa

14.3. Market Size (US$ Mn) Forecast By Region, 2017-2027

14.3.1. North America

14.3.2. Western Europe

14.3.3. Eastern Europe

14.3.4. Latin America

14.3.5. Asia Pacific Excluding Japan

14.3.6. Japan

14.3.7. Middle East and Africa

14.4. Market Attractiveness Analysis By Region

15. Global Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Drug Type

15.1. Introduction/Key Finding

15.2. Historical Market Size (US$ Mn) By Drug Type 2012-2016

15.2.1. Acyclovir

15.2.2. Valacyclovir

15.2.3. Famciclovir

15.3. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027

15.3.1. Acyclovir

15.3.2. Valacyclovir

15.3.3. Famciclovir

15.4. Market Attractiveness Analysis By Drug Type

16. Global Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration

16.1. Introduction/Key Finding

16.2. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016

16.2.1. Oral

16.2.2. Topical

16.2.3. Injectable

16.3. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

16.3.1. Oral

16.3.2. Topical

16.3.3. Injectable

16.4. Market Attractiveness Analysis By Route of Administration

17. Global Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Indication

17.1. Introduction/Key Finding

17.2. Historical Market Size (US$ Mn) By Indication, 2012-2016

17.2.1. HSV-1

17.2.2. HSV-2

17.3. Market Size (US$ Mn) Forecast By Indication, 2017-2027

17.3.1. HSV-1

17.3.2. HSV-2

17.4. Market Attractiveness Analysis By Indication

18. Global Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel

18.1. Introduction/Key Finding

18.2. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

18.2.1. Hospital Pharmacies

18.2.2. Retail Pharmacies

18.2.3. Online Pharmacies

18.2.4. Drug Stores

18.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

18.3.1. Hospital Pharmacies

18.3.2. Retail Pharmacies

18.3.3. Online Pharmacies

18.3.4. Drug Stores

18.4. Market Attractiveness Analysis By Distribution Channel

19. Global Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027

19.1. Market Size and Y-o-Y Growth

19.2. Absolute $ Opportunity

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: North America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 02: North America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 03: North America Genital Herpes Treatment Market size (US$ Mn)Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 04: North America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 05: North America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 06: North America Genital Herpes Treatment Market Participants Presence (Intensity Mapping)

Table 07: Latin America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 08: Latin America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 09: Latin America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 10: Latin America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 11: Latin America Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 12: Latin America Genital Herpes Treatment Market Participants Presence (Intensity Mapping)

Table 13: Western Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 14: Western Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 15: Western Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 16: Western Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 17: Western Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 18: Western Europe Genital Herpes Treatment Market Participants Presence (Intensity Mapping)

Table 19: Eastern Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 20: Eastern Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 21: Eastern Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 22: Eastern Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 23: Eastern Europe Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 24: Eastern Europe Genital Herpes Treatment Market Participants Presence (Intensity Mapping)

Table 25: APEJ Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 26: APEJ Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 27: APEJ Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 28: APEJ Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 29: APEJ Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 30: APEJ Genital Herpes Treatment Market Participants Presence (Intensity Mapping)

Table 31: Japan Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 32: Japan Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 33: Japan Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 34: Japan Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 35: Japan Genital Herpes Treatment Market Participants Presence (Intensity Mapping)

Table 36: MEA Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 37: MEA Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 38: MEA Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 39: MEA Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 40: MEA Genital Herpes Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 41: MEA Genital Herpes Treatment Market Participants Presence (Intensity Mapping)

Table 42: Global Genital Herpes Treatment Market Size (US$ Mn) Forecast By Region, 2012–2017

Table 43: Global Genital Herpes Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Drug Type

Table 44: Global Genital Herpes Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration

Table 45: Global Genital Herpes Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Indication

Table 46: Global Genital Herpes Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01: Global Genital Herpes Treatment Market Value Share By Drug Type 2016 (A)

Figure 02: Global Genital Herpes Treatment Market Value Share By Route of Administration 2016 (A)

Figure 03: Global Genital Herpes Treatment Market Value Share By Indication 2016 (A)

Figure 04: Global Genital Herpes Treatment Market Value Share By Distribution Channel 2016 (A)

Figure 05: Genital Herpes Treatment Market Split By Drug Type (2017)

Figure 06: Genital Herpes Treatment Market Split By Route of Administration(2017)

Figure 07: Genital Herpes Treatment Market Split By Indication(2017)

Figure 08: Genital Herpes Treatment Market Split By Distribution Channel (2017)

Figure 09: Genital Herpes Treatment Market Split By Country (2017)

Figure 10: North America Genital Herpes Treatment Market Size Analysis, 2012–2016

Figure 11: North America Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 12: U.S. Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 13: U.S. Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 14: Canada Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 15: Canada Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 16: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 17: Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 18: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 19: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 20: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 21: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 22: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 23: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 24: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 25: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 26: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 27: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 28: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 29: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 30: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 31: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 32: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 33: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 34: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 35: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 36: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 37: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 38: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 39: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 40: North America Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 

Figure 41: North America Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 42: North America Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 

Figure 43: North America Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 

Figure 44: North America Genital Herpes Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 45: Genital Herpes Treatment Market Split By Drug Type (2017)

Figure 46: Genital Herpes Treatment Market Split By Route of Administration(2017)

Figure 47: Genital Herpes Treatment Market Split By Indication(2017)

Figure 48: Genital Herpes Treatment Market Split By Distribution Channel (2017)

Figure 49: Genital Herpes Treatment Market Split By Country (2017)

Figure 50: Latin America Genital Herpes Treatment Market Size Analysis, 2012–2016

Figure 51: Latin America Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 52: Brazil Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 53: Brazil Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 54: Mexico Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 55: Mexico Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 56: Rest of Latin America Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2017

Figure 57: Rest of Latin America Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 58: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 59: Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 60: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 61: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 62: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 63: Famciclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 64: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 65: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 66: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 67: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 68: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 69: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 70: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 71: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 72: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 73: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 74: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 75: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 76: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 77: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 78: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 79: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 80: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 81: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 82: Latin America Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 

Figure 83: Latin America Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 84: Latin America Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 

Figure 85: Latin America Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 

Figure 86: Latin America Genital Herpes Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 87: Genital Herpes Treatment Market Split By Drug Type (2017)

Figure 88: Genital Herpes Treatment Market Split By Route of Administration(2017)

Figure 89: Genital Herpes Treatment Market Split By Indication(2017)

Figure 90: Genital Herpes Treatment Market Split By Distribution Channel (2017)

Figure 91: Genital Herpes Treatment Market Split By Country (2017)

Figure 92: Western Europe Genital Herpes Treatment Market Size Analysis, 2012–2016

Figure 93: Western Europe Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 94: Germany Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 95: Germany Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 96: U.K. Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 97: U.K. Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 98: France Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 99: France Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 100: Italy Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 101: Italy Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 102: Spain Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 103: Spain Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 104: Rest of Western Europe Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 105: Rest of Western Europe Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 106: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 107: Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 108: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 109: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 110: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 111: Famciclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 112: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 113: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 114: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 115: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 116: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 117: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 118: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 119: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 120: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 121: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 122: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 123: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 124: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 125: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 126: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 127: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 128: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 129: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 130: Western Europe Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 

Figure 131: Western Europe Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 132: Western Europe Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 

Figure 133: Western Europe Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 

Figure 134: Western Europe Genital Herpes Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 135: Genital Herpes Treatment Market Split By Drug Type (2017)

Figure 136: Genital Herpes Treatment Market Split By Route of Administration(2017)

Figure 137: Genital Herpes Treatment Market Split By Indication(2017)

Figure 138: Genital Herpes Treatment Market Split By Distribution Channel (2017)

Figure 139: Genital Herpes Treatment Market Split By Country (2017)

Figure 140: Eastern Europe Genital Herpes Treatment Market Size Analysis, 2012–2016

Figure 141: Eastern Europe Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 142: Russia Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 143: Russia Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 144: Poland Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 145: Poland Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 146: Rest of Eastern Europe Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 147: Rest of Eastern Europe Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 148: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 149:Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 150: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 151: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 152: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 153: Famciclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 154: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 155: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 156: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 157: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 158: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 159: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 160: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 161: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 162: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 163: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 164: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 165: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 166: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 167: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 168: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 169: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 170: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 171: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 172: Eastern Europe Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 

Figure 173: Eastern Europe Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 174: Eastern Europe Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 

Figure 175: Eastern Europe Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 

Figure 176: Eastern Europe Genital Herpes Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 177: Genital Herpes Treatment Market Split By Drug Type (2017)

Figure 178: Genital Herpes Treatment Market Split By Route of Administration(2017)

Figure 179: Genital Herpes Treatment Market Split By Indication(2017)

Figure 180: Genital Herpes Treatment Market Split By Distribution Channel (2017)

Figure 181: Genital Herpes Treatment Market Split By Country (2017)

Figure 182: APEJ Genital Herpes Treatment Market Size Analysis, 2012–2016

Figure 183: APEJ Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 184: China Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 185: China Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 186: India Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 187: India Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 188: Australia & New Zealand Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 189: Australia & New Zealand Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 190: ASEAN Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 191: ASEAN Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 192: Rest of APEJ Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 193: Rest of APEJ Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 194: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 195: Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 196: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 197: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 198: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 199: Famciclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 200: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 201: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 202: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 203: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 204: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 205: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 206: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 207: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 208: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 209: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 210: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 211: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 212: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 213: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 214: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 215: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 216: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 217: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 218: APEJ Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 

Figure 219: APEJ Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 220: APEJ Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 

Figure 221: APEJ Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 

Figure 222: APEJ Genital Herpes Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 223: Genital Herpes Treatment Market Split By Drug Type (2017)

Figure 224: Genital Herpes Treatment Market Split By Route of Administration(2017)

Figure 225: Genital Herpes Treatment Market Split By Indication(2017)

Figure 226: Genital Herpes Treatment Market Split By Country (2017)

Figure 227:Japan Genital Herpes Treatment Market Size Analysis, 2012–2016

Figure 228: Japan Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 229: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 230: Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 231: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 232: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 233: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 234: Famciclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 235: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 236: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 237: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 238: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 239: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 240: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 241: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 242: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 243: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 244: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 245: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 246: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 247: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 248: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 249: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 250: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 251: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 252: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 253: Japan Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 

Figure 254: Japan Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 255: Japan Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 

Figure 256: Japan Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 

Figure 257: Genital Herpes Treatment Market Split By Drug Type (2017)

Figure 258: Genital Herpes Treatment Market Split By Route of Administration(2017)

Figure 259: Genital Herpes Treatment Market Split By Indication(2017)

Figure 260: Genital Herpes Treatment Market Split By Distribution Channel (2017)

Figure 261: Genital Herpes Treatment Market Split By Country (2017)

Figure 262: MEA Genital Herpes Treatment Market Size Analysis, 2012–2016

Figure 263: MEA Genital Herpes Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 264: GCC Countries Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 265: GCC Countries Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 266: South Africa Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 267: South Africa Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 268: North Africa Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 269: North Africa Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 270: Rest of MEA Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 271: Rest of MEA Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 272: Acyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 273: Acyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 274: Valacyclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 275: Valacyclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 276: Famciclovir Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 277: Famciclovir Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 278: Oral Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 279: Oral Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 280: Topical Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 281: Topical Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 282: Injectable Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 283: Injectable Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 284: HSV-1 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 285: HSV-1 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 286: HSV-2 Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 287: HSV-2 Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 288: Hospital Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 289: Hospital Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 290: Retail Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 291: Retail Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 292: Online Pharmacies Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 293: Online Pharmacies Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 294: Drug Stores Genital Herpes Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 295: Drug Stores Genital Herpes Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 296: MEA Genital Herpes Treatment Market Attractiveness Analysis By Drug Class, 2017–2027 

Figure 297: MEA Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 298: MEA Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 

Figure 299: MEA Genital Herpes Treatment Market Attractiveness Analysis By Distributor Channel, 2017–2027 

Figure 300: MEA Genital Herpes Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 301: Global Genital Herpes Treatment Market Attractiveness Analysis By Region, 2017–2027 

Figure 302: Global Genital Herpes Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 303: Global Genital Herpes Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 304: Global Genital Herpes Treatment Market Attractiveness Analysis By Indication, 2017–2027 

Figure 305: Global Genital Herpes Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 306: Global Genital Herpes Treatment Market Value Analysis and Forecast, 2016–2027 (US$ Mn)

Figure 307: Global Genital Herpes Treatment Market Absolute $ Opportunity (US$ Mn), 2016–2027

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Genital Herpes Treatment Market